Clinical Trial Update: Flaxseed Lignan (Brevail) [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating flaxseed lignan Brevail for Polycystic Ovary Syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Brevail (flaxseed lignan extract (SDG))

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Polycystic Ovarian Syndrome | EARLY_Phase 1 | Status: COMPLETED